Cherry Hill Sales Recalls MakeSense Antifungal Cream Due to CGMP Deviations
Cherry Hill Sales Co. is voluntarily recalling 2,400 cartons of MakeSense PHARMA ANTIFUNGAL CREAM due to Current Good Manufacturing Practice (CGMP) deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity where adverse health consequences are temporary or medically reversible. The source text does not report any specific illnesses or injuries, and the hazard is related to manufacturing deviations rather than a specific high-risk pathogen or structural defect.
Plain-English summary
Cherry Hill Sales Co. has voluntarily initiated a recall of 2,400 cartons of MakeSense PHARMA ANTIFUNGAL CREAM 1 oz. Miconazole Nitrate 2%. The product is distributed in 1 oz. (28 g) tubes and is manufactured in China. The recall was initiated on January 27, 2017, and was terminated on April 19, 2017.
The reason for the recall is Current Good Manufacturing Practice (CGMP) deviations. The FDA classified this recall as Class II, which indicates a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
The affected product is identified by NDC 69020-208-28 and UPC 857181005092. Specific lots involved are Lot #103810 with an expiration date of 09/17 and Lot #105303 with an expiration date of 04/18. The product was distributed in Michigan, Illinois, New York, Florida, and Pennsylvania. Consumers should check their inventory for these specific lot numbers and expiration dates.
The recalled product
- Product
- MakeSense PHARMA ANTIFUNGAL CREAM 1 oz. Miconazole Nitrate 2%, 1 oz. (28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-208-28
- Manufacturer
- Cherry Hill Sales Co.
- Category
- Drug — Topical Antifungal
- Hazard
- Affected units
- 2,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #103810
- Exp. 09/17 Lot #105303
- Exp. 04/18 NDC 69020-208-28 UPC 857181005092
Distribution
Part of a larger recall action
This product is one of 5 recalled by Cherry Hill Sales Co. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Cherry Hill Sales Co.
See all →- ModerateCherry Hill Sales Recalls Hemorrhoidal Cream Due to Manufacturing Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls Medicated Anti-Itch Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls Clotrimazole Antifungal Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls MakeSense First Aid Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
Same hazard · cgmp deviations
See all →- ModerateFentanyl Citrate Injectable Solution Recall Due to cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateGlenmark Pharmaceuticals Recalls Pravastatin Sodium Tablets 80mg
FDA (Drugs) · 2025-04-16
- ModerateGlenmark Lacosamide 100mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- ModerateDrug Recall: APAP 500 mg Phenyl HCl Tablets for CGMP Deviations
FDA (Drugs) · 2022-02-16
- ModerateMigrenol Caplet Drug Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-16